Cargando…

Social Pharmacology and its impact on clinics

Detalles Bibliográficos
Autores principales:	Bansal, Seema, Mahendiratta, Saniya, Prakash, Ajay, Medhi, Bikash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764975/ https://www.ncbi.nlm.nih.gov/pubmed/34975130 http://dx.doi.org/10.4103/ijp.ijp_867_21

Ejemplares similares

Pattern of pharmacological research from the last six decades
por: Joshi, Rupa, et al.
Publicado: (2019)

Collaborative research in modern era: Need and challenges
por: Bansal, Seema, et al.
Publicado: (2019)

Specifically targeted antimicrobial peptides: A new and promising avenue in selective antimicrobial therapy
por: Sarma, Phulen, et al.
Publicado: (2018)

Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review
por: Mahendiratta, Saniya, et al.
Publicado: (2020)

Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review
por: Mahendiratta, Saniya, et al.
Publicado: (2021)

New generation vaccine: Novel approaches of vaccine design and delivery and current challenges of vaccine development
por: Bansal, Seema, et al.
Publicado: (2022)

A preliminary study to evaluate the behavior of Indian population toward E-pharmacy
por: Bansal, Seema, et al.
Publicado: (2022)

Connectomics: A pharmacologic viewpoint
por: Harikrishnareddy, Dibbanti, et al.
Publicado: (2018)

Changing trends in pharmacology…
por: Medhi, Bikash
Publicado: (2017)

Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review
por: Kumar, Subodh, et al.
Publicado: (2021)

Clinical trials for food – The gray areas: Developing countries' perspective
por: Prabha, Praisy K., et al.
Publicado: (2023)

Translational research: Bridging the gap between preclinical and clinical research
por: Mahalmani, Vidya, et al.
Publicado: (2022)

Imaging techniques in drug development
por: Gupta, Shreya, et al.
Publicado: (2022)

Do alternatives to animal experimentation replace preclinical research?
por: Mahalmani, Vidya, et al.
Publicado: (2023)

Newer potential pharmacological targets for autism spectrum disorder
por: Jain, R. Ashish, et al.
Publicado: (2019)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Three-dimensional drugs: A new era in the pharmaceutical development
por: Kumar, Harish, et al.
Publicado: (2017)

Intellectual property rights and Indian pharmaceutical industry: Present scenario
por: Prakash, Ajay, et al.
Publicado: (2018)

Drugs in sport: The curse of doping and role of pharmacologist
por: Mahendru, Dhruv, et al.
Publicado: (2019)

Artificial intelligence in pharmacovigilance: Practical utility
por: Murali, Kotni, et al.
Publicado: (2019)

Genomic biomarkers: Unveiling the potential for precise cancer therapy response
por: Kaur, Gurjeet, et al.
Publicado: (2023)

Concept of essential medicines and recent updates
por: Gupta, Shreya, et al.
Publicado: (2023)

Emerging antimicrobial resistance and newer tools to address the resistance
por: Goyal, Pardeep Kumar, et al.
Publicado: (2019)

Positive list of antibiotics and food products: Current perspective in India and across the globe
por: Mahalmani, Vidya M., et al.
Publicado: (2019)

Pattern of clinical research in the era of COVID-19 pandemic: A new learning experience for the present as well as future
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Modulation of endocannabinoid system: Success lies in the failures
por: Kumar, Subodh, et al.
Publicado: (2018)

Novel therapeutic approaches toward Hantaan virus and its clinical features’ similarity with COVID-19
por: Singh, Harvinder, et al.
Publicado: (2020)

Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Monkeypox infection: A quick glance
por: Choudhary, Gajendra, et al.
Publicado: (2022)

Structural-Based Virtual Screening of FDA-Approved Drugs Repository for NSP16 Inhibitors, Essential for SARS-COV-2 Invasion Into Host Cells: Elucidation From MM/PBSA Calculation
por: Kumar, Subodh, et al.
Publicado: (2023)

mHealth technologies in clinical trials: Opportunities and challenges
por: Kakkar, Ashish Kumar, et al.
Publicado: (2018)

In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy
por: Prajapat, Manisha, et al.
Publicado: (2020)

Impact of Organization for Economic Co-Operation and Development (OECD) principles of Good Laboratory practices (GLP) in India
por: Kapoor, Ekta, et al.
Publicado: (2021)

Questionnaire-based Pan-India survey for impact assessment of National Formulary of India
por: Sarangi, Sudhir Chandra, et al.
Publicado: (2021)

Granulocyte-colony stimulating factor improves Parkinson's disease associated with co-morbid depression: An experimental exploratory study
por: Prakash, Ajay, et al.
Publicado: (2013)

Photopharmacology
por: Sarma, Phulen, et al.
Publicado: (2017)

New undergraduate medical education curriculum
por: Mittal, Niti, et al.
Publicado: (2022)

Ecopharmacovigilance: An issue urgently to be addressed
por: Medhi, Bikash, et al.
Publicado: (2012)

An urgent need for experimental animal model of autism in drug development
por: Ruhela, Rakesh K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lb1d0m31dbpnpki6li7qnitksu